E2F1 and cancer: Further, hyper-proliferation effects in cancer have been directly ascribed to E2F1 dysregulation (Yee et al., 1987; Attwooll et al., 2004), and E2F pro-apoptotic activity is mainly attributed to E2F1 (DeGregori et al., 1997; Kent and Leone, 2019).